发明名称 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
摘要 The present invention provides nucleoside derivatives which are inhibitors of RNA-dependent RNA viral polymerase. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as inhibitors of hepatitis C virus (HCV) NS5B polymerase, as inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside derivatives alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside derivatives of the present invention.
申请公布号 EP2360166(A1) 申请公布日期 2011.08.24
申请号 EP20110151449 申请日期 2002.01.18
申请人 MERCK SHARP & DOHME CORP.;ISIS PHARMACEUTICALS, INC. 发明人 CARROLL, STEVEN, S.;LAFEMINA, ROBERT, L.;HALL, DAWN, L.;HIMMELBERGER, AMY, L.;MACCOSS, MALCOLM;OLSEN, DAVID, B.;RUTKOWSKI, CARRIE, A;KUO, LAWRENCE, C;TOMASSINI, JOANNE, E.;BHAT, BALKRISHEN;AN, HAOYUN;BHAT, NEELIMA;COOK, PHILIP, DAN;ELDRUP, ANNE, B.;GUINOSSO, CHARLES, J.;PRHAVC, MARIJA;PRAKASH, THAZHA, P.
分类号 C07D487/04;C07H19/16;A61K31/519;A61K31/70;A61K31/7052;A61K31/706;A61K31/7064;A61K31/7068;A61K31/7076;A61K31/708;A61K31/7105;A61K31/712;A61K38/21;A61K45/00;A61K45/06;A61P1/16;A61P31/14;A61P43/00;C07D473/00;C07D487/02;C07H;C07H19/00;C07H19/04;C07H19/048;C07H19/06;C07H19/067;C07H19/09;C07H19/10;C07H19/14;C07H19/167;C07H19/173;C07H19/19;C07H19/20;C12N 主分类号 C07D487/04
代理机构 代理人
主权项
地址